![]()
Daily Range
Daily RangeToday's Low
₹ 220.20
Today's High
₹ 229.00
![]()
52 Weeks Range
52 Weeks Low
₹ 80.00
52 Weeks High
₹ 148.50
![]()
Momentum of the Stock
Momentum of the Stock ![]()
Neutral
Neutral![]()
Circuit Limit
Lower
₹ 175.20
Upper
₹ 262.80
![]()
Financials Strength Score
Financials Strength Score Piotroski Score
![]()
Company Profile
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, intermediates, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitisers, antiseptics, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was incorporated in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
![]()
Companies under the same Group
Companies under the same Group
No Data Found
![]()
Key Metrics
Key MetricsStandalone
Consolidated
No of shares Outstanding
15.7 Cr.
EPS-TTM
₹-11.10
Face Value
₹2.00
Book Value
₹365.90
Net Asset Value
₹370.51
ROE
-0.52%
ROA
-0.33%
ROCE
0.43%
Dividend Yield
0.00%
Total Debt
₹ 0.0 Cr.
Sales Growth
12.72%
PAT Growth
-265.46%
Financials
| Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 1,918.4 | 1,838.7 | 1,704.1 | 1,779.0 | 1,553.6 | 1,546.2 | 1,333.1 |
| Total Non-Current Assets | 7,521.1 | 6,795.5 | 6,651.7 | 6,414.4 | 5,767.0 | 5,622.9 | 5,241.3 |
| Total Assets | 9,439.5 | 8,634.2 | 8,355.9 | 8,193.4 | 7,320.5 | 7,169.0 | 6,574.3 |
| Total Current Liabilities | 1,798.4 | 1,419.8 | 1,290.3 | 1,569.0 | 1,198.3 | 1,177.7 | 993.7 |
| Total Non-Current Liabilities | 1,831.4 | 1,665.5 | 1,366.7 | 909.4 | 743.1 | 884.0 | 766.7 |
| Shareholder's Funds | 5,809.7 | 5,548.9 | 5,698.8 | 5,715.1 | 5,379.1 | 5,107.3 | 4,814.0 |
| Total Liabilities | 9,439.5 | 8,634.2 | 8,355.9 | 8,193.4 | 7,320.5 | 7,169.0 | 6,574.3 |
![]()
Financial Statement Analysis
Current Ratio
The Industry Current Ratio stands at 2.30, vs the Current Ratio of 1.13, which results in a Negative aspect.
Quick Ratio
The Industry Quick Ratio stands at 1.60, vs the Quick Ratio of 0.76, which results in a Negative aspect.
Debt to Equity Ratio
The Industry Debt to Equity Ratio stands at 0.23, vs the Debt to Equity Ratio of 0.18, which results in a Positive aspect.
Price to BV
The Industry Price to BV stands at 7.44, vs the Price to BV of 0.53, which results in a Negative aspect.
| Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|
| Total Income | 2,412.9 | 2,140.7 | 1,912.0 | 2,043.6 | 2,058.6 | 1,694.8 | 1,713.7 |
| Total Expenditure | 2,080.7 | 1,815.0 | 1,637.8 | 1,546.0 | 1,506.7 | 1,256.8 | 1,260.3 |
| Operating Profit(Excl OI) | 360.0 | 374.8 | 312.8 | 542.0 | 605.7 | 491.0 | 479.5 |
| Add: Other Income | 27.8 | 49.1 | 38.6 | 44.5 | 53.8 | 53.0 | 26.1 |
| Operating Profit | 360.0 | 374.8 | 312.8 | 542.0 | 605.7 | 491.0 | 479.5 |
| Less: Interest | 85.7 | 56.8 | 47.6 | 62.0 | 56.6 | 48.8 | 49.0 |
| PBDT | 274.3 | 318.0 | 265.2 | 480.1 | 549.2 | 442.2 | 430.5 |
| Less: Depreciation Amortization | 280.7 | 307.6 | 307.9 | 282.9 | 240.4 | 211.4 | 213.5 |
| PBT & Exceptional Items | -6.4 | 10.4 | -42.8 | 197.2 | 308.8 | 230.8 | 217.0 |
| Less: Exceptional Income Expenses | -48.2 | -14.6 | -22.3 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit Before Tax | -54.6 | -4.3 | -65.0 | 197.2 | 308.8 | 230.8 | 216.1 |
| Less: Taxation | -24.8 | -22.3 | 100.1 | 38.7 | 98.5 | 76.2 | 70.7 |
| Profit After Tax | -29.8 | 18.0 | -165.1 | 158.5 | 210.3 | 154.6 | 145.4 |
| Earnings Per Share | -1.9 | 1.2 | -10.5 | 10.1 | 13.0 | 9.6 | 0.0 |
![]()
Financial Statement Analysis
PAT Growth
The Industry PAT Growth stands at 30.72, vs the PAT Growth of -24.64, which results in a Negative aspect.
PAT Margin
The Industry PAT Margin stands at 9.78, vs the PAT Margin of 7.76, which results in a Negative aspect.
Dividend Yield
The Industry Dividend Yield stands at 0.54, vs the Dividend Yield of 0.00, which results in a Negative aspect.
PE Ratio
The Industry PE Ratio stands at 48.79, vs the PE Ratio of 0.00, which results in a Negative aspect.
| Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|
| Profit Before Tax | -54.6 | -4.3 | -65.0 | 197.2 | 308.8 | 230.8 | 216.1 |
| Tax Paid | -34.2 | -56.3 | -51.2 | -74.4 | -129.5 | -33.6 | -115.8 |
| Adjustment | 346.8 | 325.4 | 312.5 | 330.1 | 277.2 | 235.5 | 231.8 |
| Changes In Working Capital | -54.6 | -4.3 | -65.0 | 197.2 | 308.8 | 230.8 | 216.1 |
| Cash Flow after changes in Working Capital | 254.5 | 411.2 | 563.9 | 659.5 | 411.6 | 260.0 | 418.5 |
| Cash Flow from Operating Activities | 220.3 | 354.9 | 512.7 | 585.1 | 282.0 | 226.4 | 302.7 |
| Cash Flow from Investing Activities | -448.5 | -618.5 | -380.0 | -441.7 | -169.0 | -297.2 | -142.4 |
| Cash Flow from Financing Activities | 249.7 | 130.4 | -11.0 | -97.8 | -102.2 | 77.6 | -137.1 |
| Net Cash Inflow / Outflow | 21.6 | -133.3 | 121.6 | 45.6 | 10.8 | 6.9 | 23.2 |
| Opening Cash & Cash Equivalents | 110.2 | 243.6 | 121.9 | 76.3 | 65.5 | 58.6 | 0.0 |
| Closing Cash & Cash Equivalent | 131.8 | 110.2 | 243.5 | 121.9 | 76.3 | 65.5 | 58.6 |
![]()
Financial Statement Analysis
PFCF Ratio
The Industry PFCF Ratio stands at 27.34, vs the PFCF Ratio of 5.10, which results in a Negative aspect.
PCF RATIO
The Industry PCF RATIO stands at 24.37, vs the PCF RATIO of 1.44, which results in a Negative aspect.
| Particulars | Sep 2024 | Jun 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 7,890.4 | 5,237.8 | 6,510.9 | 5,865.9 | 7,233.8 | 6,185.6 | 6,397.9 | 6,139.6 | 5,406.1 | 5,689.9 | 5,620.8 | 4,589.0 | 5,507.3 | 5,293.2 | 4,685.6 | 4,394.8 | 4,744.1 | 5,121.2 |
| Total Income | 7,956.9 | 5,252.1 | 6,571.4 | 5,950.6 | 7,299.1 | 6,253.1 | 6,462.9 | 6,228.1 | 5,462.8 | 5,733.6 | 5,811.2 | 4,685.0 | 5,611.4 | 5,352.7 | 4,775.1 | 4,544.2 | 4,830.3 | 5,333.1 |
| Total Expenditure | 6,418.9 | 4,948.1 | 6,099.8 | 5,257.4 | 6,015.2 | 5,671.2 | 5,259.2 | 5,353.6 | 4,523.2 | 5,470.0 | 4,525.8 | 3,596.7 | 4,500.9 | 4,409.6 | 4,059.5 | 3,594.3 | 4,313.5 | 3,802.3 |
| PBIDT (Excl OI) | 1,471.5 | 289.7 | 411.1 | 608.5 | 1,218.6 | 514.4 | 1,138.7 | 786.0 | 882.9 | 219.9 | 1,095.0 | 992.3 | 1,006.4 | 883.6 | 626.1 | 800.5 | 430.6 | 1,318.9 |
| Other Income | 66.5 | 14.3 | 60.5 | 84.7 | 65.3 | 67.5 | 65.0 | 88.5 | 56.7 | 43.7 | 190.4 | 96.0 | 104.1 | 59.5 | 89.5 | 149.4 | 86.2 | 211.9 |
| Operating Profit | 1,538.0 | 304.0 | 471.6 | 693.2 | 1,283.9 | 581.9 | 1,203.7 | 874.5 | 939.6 | 263.6 | 1,285.4 | 1,088.3 | 1,110.5 | 943.1 | 715.6 | 949.9 | 516.8 | 1,530.8 |
| Interest | 366.3 | 319.3 | 330.8 | 274.9 | 284.5 | 244.3 | 219.1 | 201.7 | 191.8 | 156.4 | 151.1 | 136.9 | 123.7 | 90.7 | 143.6 | 126.2 | 115.5 | 197.4 |
| Exceptional Items | -29.6 | -54.4 | 0.0 | -30.5 | 0.0 | -456.2 | -25.3 | 0.0 | 0.0 | -121.4 | 0.0 | -25.0 | 0.0 | -222.8 | 0.0 | 0.0 | 0.0 | 0.0 |
| PBDT | 1,142.1 | -69.7 | 140.8 | 387.8 | 999.4 | -118.6 | 959.3 | 672.8 | 747.8 | -14.2 | 1,134.3 | 926.4 | 986.8 | 629.6 | 572.0 | 823.7 | 401.3 | 1,333.4 |
| Depreciation | 720.9 | 705.9 | 803.7 | 750.4 | 704.5 | 757.4 | 503.3 | 795.7 | 750.8 | 838.8 | 749.5 | 740.5 | 747.1 | 767.5 | 790.8 | 784.0 | 737.0 | 735.2 |
| Profit Before Tax | 421.2 | -775.6 | -662.9 | -362.6 | 294.9 | -876.0 | 456.0 | -122.9 | -3.0 | -853.0 | 384.8 | 185.9 | 239.7 | -137.9 | -218.8 | 39.7 | -335.7 | 598.2 |
| Tax | 90.3 | 0.1 | -66.6 | 46.4 | 124.9 | -168.8 | -13.6 | -22.4 | -43.1 | -406.8 | 31.0 | 74.0 | 79.5 | 1,212.3 | -58.1 | -34.1 | -121.5 | -121.7 |
| Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit After Tax | 330.9 | -775.7 | -596.3 | -409.0 | 170.0 | -707.2 | 469.6 | -100.5 | 40.1 | -446.2 | 353.8 | 111.9 | 160.2 | -1,350.2 | -160.7 | 73.8 | -214.2 | 719.9 |
| Net Profit | 330.9 | -775.7 | -596.3 | -409.0 | 170.0 | -707.2 | 469.6 | -100.5 | 40.1 | -446.2 | 353.8 | 111.9 | 160.2 | -1,350.2 | -160.7 | 73.8 | -214.2 | 719.9 |
| ADDITIONAL INFOS: | ||||||||||||||||||
| Equity Capital | 313.6 | 313.6 | 313.6 | 313.6 | 313.6 | 313.6 | 313.6 | 313.6 | 313.6 | 313.6 | 313.6 | 313.6 | 313.6 | 313.6 | 313.6 | 313.6 | 313.6 | 313.8 |
| Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| EPS | 2.1 | -5.0 | -3.8 | -2.6 | 1.1 | -4.5 | 3.0 | -0.6 | 0.3 | -2.9 | 2.3 | 0.7 | 1.0 | -8.6 | -1.0 | 0.5 | -1.4 | 4.5 |
| Operating Profit Margin | 19.5 | 5.8 | 7.2 | 11.8 | 17.7 | 9.4 | 18.8 | 14.2 | 17.4 | 4.6 | 22.9 | 23.7 | 20.2 | 17.8 | 15.3 | 21.6 | 10.9 | 29.9 |
| Net Profit Margin | 4.2 | -14.8 | -9.2 | -7.0 | 2.4 | -11.4 | 7.3 | -1.6 | 0.7 | -7.8 | 6.3 | 2.4 | 2.9 | -25.5 | -3.4 | 1.7 | -4.5 | 14.1 |
![]()
Financial Statement Analysis
Mcap Growth
The Industry Mcap Growth stands at 19.96, vs the Mcap Growth of -75.09, which results in a Negative aspect.
Net Sales Growth
The Industry Net Sales Growth stands at 11.06, vs the Net Sales Growth of -0.73, which results in a Negative aspect.
Technicals
![]()
Pivot Levels
Pivot Levels Check Advanced Levels ![]()
| Type | Classic | Woodie | Camarilla |
|---|---|---|---|
| R4 | 243.85 | 251.83 | 231.09 |
| R3 | 238.90 | 239.45 | 228.67 |
| R2 | 233.95 | 234.23 | 227.86 |
| R1 | 230.10 | 230.65 | 227.06 |
| Pivot | 225.15 | 225.43 | 225.15 |
| S1 | 221.30 | 221.85 | 225.44 |
| S2 | 216.35 | 216.63 | 224.64 |
| S3 | 212.50 | 213.05 | 223.83 |
| S4 | 208.65 | 199.03 | 221.41 |
(All Values are in INR)
The Pivot level gives the user an indication about key support & resistance levels for a selected stock.
EMA & SMA Levels 
![]()
Beta
Beta 1 Day
1.67
1 Week
1.63
1 Month
1.56
![]()
Indicators
Stoch RSI
0.00
Bullish
RSI
29.16
Bullish
ROC
-12.95
Bearish
UltimateOscillator
39.53
Neutral
Williams Indicator
-66.25
Neutral
CCI Indicator
-104.61
Bullish
MACD
-2,774.10
Bearish
Stochastic Indicator
27.42
Neutral
ATR
13.68
High Volatility
Corporate Actions
![]()
Corporate Actions - Board Meet
Corporate Actions - Board Meet | Ex-Date | Ratio | Record Date |
|---|
| Ex-Date | Ratio | Record Date |
|---|
| Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
|---|
| Date Of Conduct | Board Meeting Details |
|---|---|
| 13-11-2024 | Quarterly Results |
| 14-02-2024 | Quarterly Results |
| 08-11-2023 | Quarterly Results |
| 09-08-2023 | Quarterly Results |
| 23-05-2023 | Audited Results |
| 10-03-2023 | Inter alia, to consider and approve the proposal of fund raising by way of issuance of Non-Convertible Debentures, by way of private placement, subject to such regulatory or statutory approvals as may be required |
| 10-02-2023 | Quarterly Results |
| 17-01-2023 | Inter alia, to consider and approve the proposal of fund raising by way of issuance of Non-Convertible Debentures, by way of private placement, in one or more tranche or tranches, subject to such regulatory or statutory approvals as may be required. |
| 11-11-2022 | Quarterly Results |
| 09-08-2022 | Quarterly Results |
| 10-05-2022 | Audited Results |
| 03-02-2022 | Quarterly Results |
| 28-10-2021 | Quarterly Results |
| 12-08-2021 | Quarterly Results |
| 16-06-2021 | Employees Stock Option Plan(Cancelled) |
| 11-05-2021 | Audited Results |